- Home
- LWAY vs SLDB Comparison
LWAY vs SLDB Comparison
Compare LWAY & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LWAY
- SLDB
- Stock Information
- Founded
- LWAY 1986
- SLDB 2013
- Country
- LWAY United States
- SLDB United States
- Employees
- LWAY N/A
- SLDB N/A
- Industry
- LWAY Packaged Foods
- SLDB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LWAY Consumer Staples
- SLDB Health Care
- Exchange
- LWAY Nasdaq
- SLDB Nasdaq
- Market Cap
- LWAY 513.4M
- SLDB 464.1M
- IPO Year
- LWAY 1987
- SLDB 2018
- Fundamental
- Price
- LWAY $25.54
- SLDB $4.10
- Analyst Decision
- LWAY Strong Buy
- SLDB Strong Buy
- Analyst Count
- LWAY 1
- SLDB 10
- Target Price
- LWAY $33.00
- SLDB $14.90
- AVG Volume (30 Days)
- LWAY 77.8K
- SLDB 1.0M
- Earning Date
- LWAY 11-13-2025
- SLDB 11-03-2025
- Dividend Yield
- LWAY N/A
- SLDB N/A
- EPS Growth
- LWAY N/A
- SLDB N/A
- EPS
- LWAY 0.70
- SLDB N/A
- Revenue
- LWAY $193,021,000.00
- SLDB N/A
- Revenue This Year
- LWAY $14.66
- SLDB N/A
- Revenue Next Year
- LWAY $13.81
- SLDB N/A
- P/E Ratio
- LWAY $34.59
- SLDB N/A
- Revenue Growth
- LWAY 9.19
- SLDB N/A
- 52 Week Low
- LWAY $19.50
- SLDB $2.41
- 52 Week High
- LWAY $34.20
- SLDB $7.37
- Technical
- Relative Strength Index (RSI)
- LWAY 31.29
- SLDB 28.04
- Support Level
- LWAY $23.46
- SLDB $3.93
- Resistance Level
- LWAY $24.99
- SLDB $6.09
- Average True Range (ATR)
- LWAY 0.82
- SLDB 0.40
- MACD
- LWAY -0.15
- SLDB -0.19
- Stochastic Oscillator
- LWAY 19.82
- SLDB 7.54
About LWAY Lifeway Foods Inc.
Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir which is a cultured dairy product. Its product categories are Drinkable Kefir which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir and Other dairy. The company manufacture and market products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through direct sales force, brokers, and distributors.
About SLDB Solid Biosciences Inc.
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.